梅斯健康(02415)发布2024年度业绩,股东应占溢利2496.7万元,同比下降54.6%

智通财经
28 Mar

智通财经APP讯,梅斯健康(02415)发布2024年度业绩,收益2.61亿元(人民币,下同),同比下降25.4%;母公司拥有人应占溢利2496.7万元,同比下降54.6%;每股基本盈利0.05元。

期内总收益同比减少,主要是由于制药及医疗器械公司以及医院医生所面临当前国家标准的合规要求提高,其合规性审查时间延长,因而延长了项目执行时间;及2024年医保谈判和药品集采政策的持续推进,导致药品和医疗器械的利润空间被压缩,制药及医疗器械公司因此减少了营销预算。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10